NAMA
CRSP icon

Nikko Asset Management Americas’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$117M Sell
2,414,271
-125,618
-5% -$6.11M 1.17% 23
2025
Q1
$86.3M Sell
2,539,889
-205,787
-7% -$6.99M 1.11% 24
2024
Q4
$108M Sell
2,745,676
-221,543
-7% -$8.72M 1.17% 25
2024
Q3
$139M Sell
2,967,219
-184,295
-6% -$8.66M 1.58% 19
2024
Q2
$170M Sell
3,151,514
-117,271
-4% -$6.33M 1.96% 16
2024
Q1
$223M Sell
3,268,785
-100,977
-3% -$6.88M 2.21% 13
2023
Q4
$211M Sell
3,369,762
-95,708
-3% -$5.99M 2.03% 13
2023
Q3
$157M Sell
3,465,470
-67,887
-2% -$3.08M 1.88% 14
2023
Q2
$198M Sell
3,533,357
-438,782
-11% -$24.6M 2.09% 15
2023
Q1
$179M Sell
3,972,139
-34,337
-0.9% -$1.55M 2.06% 16
2022
Q4
$163M Sell
4,006,476
-256,260
-6% -$10.4M 2.35% 14
2022
Q3
$277M Sell
4,262,736
-321,362
-7% -$20.9M 3.54% 9
2022
Q2
$276M Sell
4,584,098
-35,649
-0.8% -$2.15M 3.41% 9
2022
Q1
$291M Buy
4,619,747
+300,276
+7% +$18.9M 2.14% 15
2021
Q4
$331M Buy
4,319,471
+1,029,955
+31% +$78.8M 1.74% 17
2021
Q3
$368M Sell
3,289,516
-93,940
-3% -$10.5M 1.58% 21
2021
Q2
$548M Sell
3,383,456
-276,409
-8% -$44.8M 2.15% 13
2021
Q1
$446M Sell
3,659,865
-176,958
-5% -$21.6M 2.18% 11
2020
Q4
$587M Buy
3,836,823
+139,156
+4% +$21.3M 3.34% 4
2020
Q3
$309M Sell
3,697,667
-14,303
-0.4% -$1.19M 2.74% 7
2020
Q2
$269M Sell
3,711,970
-54,571
-1% -$3.96M 3.53% 5
2020
Q1
$160M Buy
3,766,541
+716,988
+24% +$30.4M 2.97% 6
2019
Q4
$186M Buy
3,049,553
+272,139
+10% +$16.6M 2.92% 6
2019
Q3
$114M Buy
2,777,414
+906,006
+48% +$37.1M 2.02% 13
2019
Q2
$88.1M Buy
1,871,408
+1,430,364
+324% +$67.4M 1.73% 16
2019
Q1
$15.8M Buy
441,044
+440,120
+47,632% +$15.7M 0.42% 50
2018
Q4
$26K Sell
924
-200
-18% -$5.63K ﹤0.01% 137
2018
Q3
$50K Buy
+1,124
New +$50K ﹤0.01% 132